Summit Therapeutics on the Cusp: A Dual-Action Lung Cancer Drug Faces its Moment of Truth
The Curious Case of Nkarta: Why This Biotech's Value Might Be Hiding in Plain Sight
Immunocore at the Crossroads: Steady Hands and the Search for Tomorrow's Breakthrough